FrancophonIA/ELRC3.0 huggingface dataset:
English: Appendix V. By reporting side effects you can help provide more information on the safety of this medicine.
Slovenian: O neželenih učinkih lahko poročate tudi neposredno na nacionalni center za poročanje, ki je naveden v Prilogi V. S tem, ko poročate o neželenih učinkih, lahko prispevate k zagotovitvi več informacij o varnosti tega zdravila.
English: OHSS should be treated symptomatically, e.g. with rest, intravenous infusion of electrolyte solutions or colloids and heparin.
Slovenian: OHSS je treba zdraviti simptomatsko, to je s počitkom, intravensko infuzijo elektrolitov ali s koloidi in heparinom.
English: In patients undergoing controlled ovarian stimulation the median duration of Orgalutran treatment was 5 days.
Slovenian: Pri bolnicah, ki so bile vključene v postopek nadzorovane stimulacije jajčnikov, je bila mediana vrednost dolžine zdravljenja z zdravilom Orgalutran 5 dni.
English: The start of Orgalutran may be delayed in absence of follicular growth, although clinical experience is based on starting Orgalutran on day 5 or day 6 of stimulation.
Slovenian: Začetek zdravljenja z zdravilom Orgalutran se lahko zakasni, če ni rasti folikla, vendar klinične izkušnje temeljijo na začetku uporabe zdravila Orgalutran na 5. ali 6. dan stimulacije.
English: Pharmacotherapeutic group: Pituitary and hypothalamic hormones and analogues, anti-gonadotrophin-releasing hormones, ATC code: H01CC01.
Slovenian: Farmakoterapevtska skupina: Hipofizni in hipotalamični hormoni ter sorodne učinkovine, antagonisti gonadotropin sproščajočih hormonov, oznaka ATC: H01CC01.
English: Use only syringes with clear, particle-free solutions and from undamaged containers.
Slovenian: Uporabite samo brizge z bistro raztopino, brez vidnih delcev in iz nepoškodovanih vsebnikov.
English: In clinical studies investigating more than 1,000 newborns it has been demonstrated that the incidence of congenital malformations in children born after COH treatment using Orgalutran is comparable with that reported after COH treatment using a GnRH agonist.
Slovenian: Klinične študije, v katerih so preiskovali več kot 1.000 novorojenčkov, so pokazale, da je pogostnost kongenitalnih malformacij pri otrocih, ki so bili rojeni po zdravljenju s COH z uporabo zdravila Orgalutran primerljiva s tistimi, o katerih so poročali po zdravljenju s COH z uporabo GnRH agonistov.
English: In the absence of clinical experience, Orgalutran treatment is not advised in women with severe allergic conditions.
Slovenian: Zaradi pomanjkanja kliničnih izkušenj uporaba zdravila Orgalutran ni priporočljiva za ženske s hudimi alergijami.
English: If you use more Orgalutran than you should Contact your doctor.
Slovenian: Če ste uporabili večji odmerek zdravila Orgalutran, kot bi smeli Obvestite zdravnika.
English: OHSS must be considered an intrinsic risk of gonadotrophin stimulation.
Slovenian: OHSS je treba šteti za pričakovano tveganje pri stimulaciji z gonadotropini.
English: In women undergoing assisted reproduction techniques, including in vitro fertilisation (IVF) and other methods, occasionally ovulation may occur too early causing a significant reduction in the chance of getting pregnant.
Slovenian: Pri ženskah, ki so podvržene reprodukcijskim tehnikam, vključno z in vitro oploditvijo (IVF) in ostalimi metodami, se občasno lahko pojavi prezgodnja ovulacija, kar povzroči znatno zmanjšanje možnosti za zanositev.
English: This is thought to be due to differences in parental characteristics (e.g. maternal age, sperm characteristics) and an increased incidence of multiple gestations.
Slovenian: Menijo, da je to posledica razlik v lastnostih staršev (npr. starost matere, značilnosti spermijev) in povečane pogostnosti večkratnih nosečnosti.
English: LH is needed to release the mature egg cells from the follicles and ovaries (i.e. ovulation).
Slovenian: LH je potreben za sprostitev dozorelih jajčnih celic iz foliklov in jajčnikov (npr. ovulacija).
English: In acute toxicity studies in rats and monkeys non-specific toxic symptoms such as hypotension and bradycardia were only observed after intravenous administration of ganirelix over 1 and 3 mg/kg, respectively.
Slovenian: V študijah akutne toksičnosti pri podganah in opicah so opazili nespecifične toksične simptome, npr. hipotenzijo in bradikardijo samo po intravenskem dajanju ganireliksa v odmerku nad 1 mg oziroma 3 mg/kg.
English: Orgalutran should only be prescribed by a specialist experienced in the treatment of infertility.
Slovenian: Zdravilo Orgalutran sme predpisati le specialist, ki je izkušen v zdravljenju neplodnosti.
English: Do not stop using Orgalutran unless advised to by your doctor, as this may affect the outcome of your treatment.
Slovenian: Če ste prenehali uporabljati zdravilo Orgalutran Ne prenehajte z jemanjem zdravila Orgalutran, če vam tega ne svetuje zdravnik, ker bi lahko tako spremenili izid zdravljenja.
English: Insert the needle at the base of the pinched-up skin at an angle of 45° to the skin surface.
Slovenian: Potisnite iglo v kožo, ki jo držite med prstoma, pod kotom 45 na površino kože.
English: Orgalutran is available in packs of 1 or 5 pre-filled syringes.
Slovenian: Zdravilo Orgalutran je na voljo v pakiranjih z 1 ali 5 napolnjenimi injekcijskimi brizgami.
English: The starting day of Orgalutran is depending on the ovarian response, i.e. the number and size of growing follicles and/or the amount of circulating oestradiol.
Slovenian: Začetek dajanja zdravila Orgalutran je odvisen od odziva jajčnikov, tj. števila in velikosti rastočih foliklov in/ali količine estradiola v krvi.
English: The other ingredients are acetic acid, mannitol, water for injections.
Slovenian: - Druge sestavine zdravila so ocetna kislina, manitol, voda za injekcije.
English: Daily treatment with Orgalutran should be continued up to the day that sufficient follicles of adequate size are present.
Slovenian: Dnevno zdravljenje z zdravilom Orgalutran moramo nadaljevati do dneva, ko nastane dovolj veliko število foliklov primerne velikosti.
English: In controlled studies of Orgalutran with FSH, using a long protocol of GnRH agonist as a reference, treatment with the Orgalutran regimen resulted in a faster follicular growth during the first days of stimulation but the final cohort of growing follicles was slightly smaller and produced on average less oestradiol.
Slovenian: V kontroliranih študijah z uporabo zdravila Orgalutran in FSH z uporabo dolgega protokola agonista GnRH kot referenčnega zdravila je zdravljenje z zdravilom Orgalutran povzročilo hitrejšo rast foliklov v prvih dneh stimulacije, vendar pa je bilo končno skupno število rastočih foliklov nekoliko manjše, s povprečno manjšo količino estradiola.
English: Reproduction studies carried out with ganirelix at doses of 0.1 to 10 g/kg/day subcutaneously in the rat and 0.1 to 50 g/kg/day subcutaneously in the rabbit showed increased litter resorption in the highest dose groups.
Slovenian: Študije vpliva na sposobnost razmnoževanja, opravljene s subkutanimi odmerki ganireliksa od 0,1 do 10 g/kg/dan pri podganah in z odmerki od 0,1 do 50 g/kg/dan pri kuncih so pokazale povečano resorpcijo zarodkov pri skupinah, ki so prejemale največje odmerke.
English: Very common: may affect more than 1 in 10 women Local skin reactions at the site of injection (predominantly redness, with or without swelling).
Slovenian: Zelo pogosti: pojavijo se lahko pri več kot 1 od 10 bolnic - lokalne kožne reakcije na mestu injiciranja (predvsem pordelost, z oteklino ali brez).
English: Moderate or severe impairment of renal or hepatic function.
Slovenian: - Zmerna ali huda okvara delovanja ledvic ali jeter.
English: Pregnancy complications
Slovenian: Zapleti pri nosečnosti
English: The metabolite profile of Orgalutran in humans was similar to that found in animals.
Slovenian: Profil presnovkov zdravila Orgalutran pri človeku je podoben profilu pri živalih.
English: What you need to know before you use Orgalutran
Slovenian: Kaj morate vedeti, preden boste uporabili zdravilo Orgalutran
English: Orgalutran (0.25 mg) should be injected just under the skin once daily, starting on day 5 or day 6 of stimulation.
Slovenian: Zdravilo Orgalutran (0,25 mg) je treba injicirati neposredno pod kožo enkrat dnevno, z začetkom na 5. ali 6. dan stimulacije.
English: There is a slightly increased risk of pregnancy outside of the uterus (an ectopic pregnancy) in women with damaged fallopian tubes.
Slovenian: Obstaja rahlo povečano tveganje za nosečnost zunaj maternice (zunajmaternično nosečnost) pri ženskah s prizadetimi jajcevodi.
English: The use of Orgalutran is contraindicated during pregnancy and breast-feeding (see section 4.3).
Slovenian: Uporaba zdravila Orgalutran je kontraindicirana v času nosečnosti in dojenja (glejte poglavje 4.3).
English: The time between two Orgalutran injections as well as the time between the last Orgalutran injection and hCG injection should not exceed 30 hours, as otherwise a premature ovulation (i.e. release of egg cells) may occur.
Slovenian: Časovni razmik med dvema injekcijama zdravila Orgalutran kakor tudi časovni razmik med zadnjo injekcijo zdravila Orgalutran ter injekcijo hCG ne sme biti daljši od 30 ur, ker lahko v nasprotnem primeru nastopi prezgodnja ovulacija (npr. sprostitev jajčnih celic).
English: During or following hormonal stimulation of the ovaries, ovarian hyperstimulation syndrome may develop.
Slovenian: Med ali po hormonski stimulaciji jajčnikov se lahko razvije sindrom hiperstimulacije jajčnikov.
English: After a single subcutaneous administration of 0.25 mg, serum levels of ganirelix rise rapidly and reach peak levels (Cmax) of approximately 15 ng/mL within 1 to 2 hours (tmax).
Slovenian: Po enkratnem subkutanem odmerku 0,25 mg, serumske koncentracije ganireliksa hitro narastejo in dosežejo maksimalno koncentracijo (Cmax) približno 15 ng/ml v 1 do 2 urah (tmax).
English: What Orgalutran is and what it is used for What you need to know before you use Orgalutran How to use Orgalutran
Slovenian: Kaj je zdravilo Orgalutran in za kaj ga uporabljamo Kaj morate vedeti, preden boste uporabili zdravilo Orgalutran Kako uporabljati zdravilo Orgalutran Možni neželeni učinki
English: After repeated dosing 0.25 mg/day steady-state levels of approximately 0.6 ng/mL were reached within 2 to 3 days.
Slovenian: Po večkratnem odmerjanju 0,25 mg/dan so bile vrednosti v stanju dinamičnega ravnovesja približno 0,6 ng/ml dosežene v 2 do 3 dneh.
English: FSH dose adjustments should be based on the number and size of growing follicles, rather than on the amount of circulating oestradiol (see section 5.1).
Slovenian: Odmerek FSH raje prilagodite glede na število in velikost rastočih foliklov kot glede na količino estradiola v krvi (glejte poglavje 5.1.
English: Disposable pre-filled syringes (siliconised type I glass), containing 0.5 mL of sterile, ready for use, aqueous solution closed with a rubber piston that does not contain latex.
Slovenian: Napolnjene injekcijske brizge za enkratno uporabo (silikonizirano steklo tipa I) vsebujejo po 0,5 ml sterilne vodne raztopine, pripravljene za uporabo, in so zaprte z gumijastim batom, ki ne vsebuje lateksa.
English: Other medicines and Orgalutran Tell your doctor or pharmacist if you are using, have recently used or might use any other medicines.
Slovenian: Obvestite zdravnika ali farmacevta, če uporabljate, ste pred kratkim uporabljali ali pa boste morda začeli uporabljati katero koli drugo zdravilo.
English: Orgalutran (0.25 mg) should be injected subcutaneously once daily, starting on day 5 or day 6 of FSH administration or on day 5 or day 6 following the administration of corifollitropin alfa.
Slovenian: Zdravilo Orgalutran (0,25 mg) je treba injicirati subkutano enkrat na dan, z začetkom na 5. ali 6. dan dajanja FSH ali na 5. ali 6. dan po dajanju korifolitropina alfa.
English: Initiation of Orgalutran treatment on day 5 can prevent these premature LH rises without compromising the clinical outcome.
Slovenian: Z začetkom zdravljenja z zdravilom Orgalutran na 5. dan stimulacije pa se lahko prepreči to prezgodnje zvišanje koncentracije LH, ne da bi ogrozili klinični izid zdravljenja.
English: This medicinal product contains less than 1 mmol sodium (23 mg) per injection, i.e. essentially ‘sodium-free'.
Slovenian: To zdravilo vsebuje manj kot 1 mmol (23 mg) natrija na injekcijo, kar v bistvu pomeni ‘brez natrija'.
English: EU/1/00/130/001, 1 pre-filled syringe EU/1/00/130/002, 5 pre-filled syringes
Slovenian: EU/1/00/130/001, 1 napolnjena injekcijska brizga EU/1/00/130/002, 5 napolnjenih injekcijskih brizg
English: Remove needle cover.
Slovenian: Odstranite zaščitni pokrovček z igle.
English: Paediatric population There is no relevant use of Orgalutran in the paediatric population.
Slovenian: Pediatrična populacija Zdravilo Orgalutran ni namenjeno za uporabo pri pediatrični populaciji.
English: Hypersensitivity to gonadotrophin-releasing hormone (GnRH) or any other GnRH analogue.
Slovenian: - Preobčutljivost na gonadotropin sproščujoči hormon (GnRH) ali kateri drug analog GnRH.
English: EU/1/00/130/001 1 pre-filled syringe EU/1/00/130/002 5 pre-filled syringes
Slovenian: EU/1/00/130/001 1 napolnjena injekcijska brizga EU/1/00/130/002 5 napolnjenih injekcijskih brizg
English: Driving and using machines The effects of Orgalutran on ability to drive and use machines have not been studied.
Slovenian: Vpliv na sposobnost upravljanja vozil in strojev Študije o vplivu zdravila Orgalutran na sposobnost vožnje in upravljanja strojev niso bile izvedene.
English: Controlled ovarian hyperstimulation with FSH or corifollitropin alfa may start at day 2 or 3 of menses.
Slovenian: Nadzorovana hiperstimulacija jajčnikov z FSH ali korifolitropinom alfa se lahko začne na 2. ali 3. dan menstruacije.
English: GnRH regulates the release of gonadotrophins (luteinising hormone (LH) and follicle stimulating hormone (FSH)).
Slovenian: GnRH uravnava sproščanje gonadotropinov (luteinizirajočega hormona (LH) in folikle stimulirajočega hormona (FSH)).
English: The needle cover contains dry natural rubber/latex which comes into contact with the needle and may cause allergic reactions (see section 6.5).
Slovenian: Pokrovček igle vsebuje suho naravno gumo/lateks, ki pride v stik z iglo in lahko povzroči alergijske reakcije (glejte poglavje 6.5).
English: Orgalutran is supplied in pre-filled syringes and should be injected slowly, just under the skin, preferably in the upper leg.
Slovenian: Zdravilo Orgalutran je na voljo v napolnjenih injekcijskih brizgah in ga je treba injicirati počasi, tik pod kožo, najbolje v stegno.
English: There was a tendency towards an increased incidence of LH and progesterone rises in women with a higher body weight (> 80 kg), but no effect on clinical outcome was observed.
Slovenian: Ženske z večjo telesno maso (> 80 kg) so bile nagnjene k večji pogostnosti zvišanja vrednosti LH in progesterona, vendar niso opažali nobenega učinka na klinični izid.
English: Inspect the syringe before use.
Slovenian: Pred uporabo preglejte raztopino.
English: Clean about 5 cm (two inches) around the point where the needle will go in and let the disinfectant dry for at least one minute before proceeding.
Slovenian: Očistite približno pet centimetrov okoli mesta injiciranja in počakajte vsaj eno minuto, da se razkužilo posuši, preden postopek nadaljujete.
English: Removing the syringe
Slovenian: Odstranjevanje brizge
English: If you forget to use Orgalutran
Slovenian: Če ste pozabili uporabiti zdravilo Orgalutran
English: Orgalutran is used to prevent the premature LH surge that might cause such a premature release of egg cells.
Slovenian: Zdravilo Orgalutran se uporablja za preprečevanje prezgodnjega dviga LH, ki lahko povzroči takšno prezgodnjo sprostitev jajčnih celic.
English: In addition, side effects are reported which are known to occur with controlled ovarian hyperstimulation treatment (e.g. abdominal pain, ovarian hyperstimulation syndrome (OHSS), ectopic pregnancy (when the embryo develops outside the womb) and miscarriage (see the patientinformation leaflet of the FSH-containing preparation you are treated with)).
Slovenian: Poleg tega so poročali tudi o drugih neželenih učinkih, za katere je znano, da se pojavljajo pri kontrolirani hiperstimulaciji jajčnikov (npr. trebušne bolečine, sindrom hiperstimulacije jajčnikov (OHSS), zunajmaternična nosečnost (kadar se zarodek razvija zunaj maternice) in splav (glejte navodilo za uporabo za FSH vsebujoče zdravilo, s katerim vas zdravijo)).
English: Reported in one subject after the first Orgalutran dose.
Slovenian: Poročano pri eni osebi po prejetem prvem odmerku zdravila Orgalutran.
English: Other ingredients: acetic acid, mannitol, water for injections, sodium hydroxide and/or acetic acid as pH adjustment.
Slovenian: Pomožne snovi: ocetna kislina, manitol, voda za injekcije, natrijev hidroksid in/ali ocetna kislina za uravnavanje pH.
English: Pregnancy or breast-feeding.
Slovenian: - Nosečnost ali dojenje.
English: Timing of last injection
Slovenian: Kdaj dati zadnjo injekcijo
English: This slightly higher incidence is thought to be related to characteristics of the patients undergoing fertility treatment (e.g. age of the woman, sperm characteristics) and to the higher incidence of multiple gestations after assisted reproduction techniques.
Slovenian: Ta nekoliko večja pogostnost je verjetno povezana s karakteristikami bolnikov, ki se zdravijo za neplodnostjo (npr. starost ženske, karakteristike sperme), in z večjo pogostnostjo večplodne nosečnosti po postopku oploditve z biomedicinsko pomočjo.
English: )If a hypersensitivity reaction is suspected, Orgalutran should be discontinued and appropriate treatment administered.
Slovenian: Če obstaja sum na preobčutljivostno reakcijo, je treba zdravljenje z zdravilom Orgalutran prekiniti in uvesti ustrezno zdravljenje.
English: The table below shows all adverse reactions in women treated with Orgalutran in clinical studies using recFSH for ovarian stimulation.
Slovenian: V spodnji preglednici so prikazani vsi neželeni učinki pri ženskah, zdravljenih z zdravilom Orgalutran v kliničnih študijah, v katerih je bil za stimulacijo jajčnikov uporabljen recFSH.
English: OUTER CARTON TEXT Orgalutran 1/ 5 pre-filled syringes
Slovenian: BESEDILO NA ZUNANJI OVOJNINI zdravila Orgalutran 1/ 5 napolnjenih injekcijskih brizg
English: Ovarian stimulation with follicle stimulating hormone (FSH) or corifollitropin may start at day 2 or 3 of your period.
Slovenian: Stimulacija jajčnikov s folikle stimulirajočim hormonom (FSH) ali korifolitropinom se lahko prične na 2. ali 3. dan vaše menstruacije.
English: Preparing the injection site
Slovenian: Priprava mesta injiciranja
English: Other reported adverse reactions are related to the controlled ovarian hyperstimulation treatment for ART, notably pelvic pain, abdominal distension, OHSS (see also section 4.4), ectopic pregnancy and spontaneous abortion.
Slovenian: Drugi poročani neželeni učinki so povezani z nadzorovano hiperstimulacijo jajčnikov pri postopku oploditve z biomedicinsko pomočjo, na primer: predvsem bolečine v medenici, napihnjenost trebuha, OHSS (glejte tudi poglavje 4.4), ektopična nosečnost in spontani splav.
English: Because of the half-life of ganirelix, the time between two Orgalutran injections as well as the time between the last Orgalutran injection and the hCG injection should not exceed 30 hours, as otherwise a premature LH surge may occur.
Slovenian: Zaradi razpolovnega časa ganireliksa časovni razmik med dvema injekcijama zdravila Orgalutran ter časovni razmik med zadnjo injekcijo zdravila Orgalutran ter injekcijo hCG ne sme presegati 30 ur, ker lahko v nasprotnem primeru nastopi prezgodnji vrh sproščanja LH.
English: This different pattern of follicular growth requires that FSH dose adjustments are based on the number and size of growing follicles, rather than on the amount of circulating oestradiol.
Slovenian: Zaradi različnega načina rasti foliklov je treba odmerek FSH prilagoditi raje glede na število in velikost rastočih foliklov kot glede na količino estradiola v krvi.
English: Allergic reactions, both generalised and local, including hives (urticaria), swelling of the face, lips tongue, and/or throat that may cause difficulty in breathing and/or swallowing (angioedema and/or anaphylaxis) have been reported.
Slovenian: Poročali so o alergijskih reakcijah, generaliziranih in lokalnih, vključno s koprivnico (urtikarijo), otekanjem obraza, ustnic, jezika in/ali grla, ki lahko povzročijo težave pri dihanju in/ali požiranju (angioedem in/ali anafilaksija) (glejte tudi poglavje 4).
English: If this happens, do not inject Orgalutran, but remove the syringe, cover the injection site with a swab containing disinfectant and apply pressure; bleeding should stop in a minute or two.
Slovenian: Če se to zgodi, ne smete injicirati zdravila Orgalutran, ampak potegnite brizgo z iglo ven, pokrijte mesto injiciranja z blazinico, namočeno v razkužilo, in pritisnite.
English: Final maturation of the egg cells in the follicles can be induced by administering human chorionic gonadotrophin (hCG).
Slovenian: Končno zorenje jajčnih celic v foliklih lahko sprožimo z dajanjem humanega horionskega gonadotropina (hCG).
English: Any blood drawn into the syringe means the needle tip has penetrated a blood vessel.
Slovenian: Če pride kri v brizgo, to pomeni, da je konica igle prišla v žilo.
English: Solution for injection, 1 pre-filled syringe containing 0.5 mL Solution for injection, 5 pre-filled syringes each containing 0.5 mL
Slovenian: raztopina za injiciranje, 1 napolnjena injekcijska brizga z 0,5 ml raztopine raztopina za injiciranje, 5 napolnjenih injekcijskih brizg z 0,5 ml raztopine
English: Orgalutran is used as part of the treatment for assisted reproduction techniques (ART) including in vitro fertilisation (IVF).
Slovenian: Zdravilo Orgalutran se uporablja kot del zdravljenja pri postopkih oploditve z biomedicinsko pomočjo (ART) ter in vitro oploditvi (IVF).
English: Pull the syringe out quickly and apply pressure to the site with a swab containing disinfectant.
Slovenian: Hitro potegnite brizgo z iglo iz kože in pritisnite na mesto injiciranja z blazinico, namočeno v razkužilo.
English: Medicinal product subject to restricted medical prescription (see annex I: Summary of Product Characteristics, section 4.2).
Slovenian: Predpisovanje in izdaja zdravila je le na recept s posebnim režimom (glejte Prilogo I: Povzetek glavnih značilnosti zdravila, poglavje 4.2).
English: Preclinical data reveal no special hazard for humans based on safety pharmacology, repeated dose toxicity and genotoxicity.
Slovenian: Predklinični podatki na osnovi običajnih študij farmakološke varnosti, toksičnosti pri ponavljajočih odmerkih in genotoksičnosti ne kažejo posebnega tveganja za človeka.
English: Overdose in humans may result in a prolonged duration of action.
Slovenian: Pri ljudeh lahko preveliko odmerjanje povzroči podaljšano delovanje zdravila Orgalutran.
English: The incidence of congenital malformations after assisted reproduction techniques using Orgalutran is not different from that after using other GnRH analogues in the course of assisted reproduction techniques.
Slovenian: Pogostnost pojavljanja prirojenih nepravilnosti v razvoju raznih delov telesa po postopku oploditve z biomedicinsko pomočjo z uporabo zdravila Orgalutran, se ne razlikuje od tistih, z uporabo drugih GnRH analogov v postopku oploditve z biomedicinsko pomočjo.
English: The adverse reactions with Orgalutran using corifollitropin alfa for ovarian stimulation are expected to be similar.
Slovenian: Pričakuje se, da so neželeni učinki pri uporabi zdravila Orgalutran in korifolitropina alfa za stimulacijo jajčnikov podobni.
English: When injecting Orgalutran in the afternoon the last Orgalutran injection should be given in the afternoon prior to the day of triggering ovulation.
Slovenian: Pri injiciranju zdravila Orgalutran popoldan je treba zadnjo injekcijo zdravila Orgalutran dati popoldan pred dnem sproženja ovulacije.